The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease
暂无分享,去创建一个
P. Bedossa | S. Koduru | A. Sanyal | C. Alonso | Suresh R. Giri | Mukul R Jain | R. Caffrey | Prasanna K. Santhekadur | M. Bhat | B. Philip | Divya P. Kumar | Jonathon Marioneaux